3SBio Inc., a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in China (CN) and operates extensively across major regions in Asia. Founded in 1993, the company has achieved significant milestones, establishing itself as a leader in the development and production of biopharmaceuticals.
Specialising in innovative therapies, 3SBio focuses on areas such as oncology, nephrology, and autoimmune diseases. Its core products, including recombinant proteins and monoclonal antibodies, are distinguished by their high quality and efficacy, catering to the evolving needs of healthcare providers and patients alike. With a strong market position, 3SBio has garnered recognition for its commitment to research and development, contributing to advancements in the biopharmaceutical landscape.
-18 vs industry average
3sbio’s score of 20 is lower than 27% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at 3sbio?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
3sbio's reported carbon emissions
3SBio, a pharmaceutical preparation manufacturing company headquartered in China, reported its latest carbon emissions data for 2024, with a total of approximately 69.14 million kg CO2e. This figure comprises Scope 1 emissions of about 13.30 million kg CO2e and Scope 2 emissions of approximately 55.83 million kg CO2e (market-based). For 2023, 3SBio's combined Scope 1 and 2 emissions were approximately 60.65 million kg CO2e, with Scope 1 at about 11.66 million kg CO2e and Scope 2 at approximately 48.99 million kg CO2e (location-based). In 2022, the company's total Scope 1 and 2 emissions amounted to around 45.90 million kg CO2e, consisting of 7.26 million kg CO2e for Scope 1 and about 38.64 million kg CO2e for Scope 2 (location-based). Earlier data from 2021 shows combined Scope 1 and 2 emissions of approximately 56.21 million kg CO2e, with Scope 1 at about 6.59 million kg CO2e and Scope 2 at roughly 49.62 million kg CO2e. In 2020, Scope 1 and 2 emissions totalled around 47.72 million kg CO2e, with Scope 1 at approximately 6.52 million kg CO2e and Scope 2 at about 41.20 million kg CO2e. The company's Scope 1 and 2 emissions for 2019 were approximately 48.69 million kg CO2e, broken down into 5.96 million kg CO2e for Scope 1 and 42.72 million kg CO2e for Scope 2. 3SBio has not publicly disclosed specific reduction targets or commitments for Scope 3 emissions, which were not reported in the provided data. The company's available emissions data covers Scope 1 and Scope 2.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
3sbio’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for 3sbio yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
3sbio
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project